Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ferring reveals novel DPP-IV inhibitors in recent patents

May 21, 2003

Butanediol esters as potential new bone resorption inhibitors

May 20, 2003

Lipid-lowering effects of ezetimibe in hypercholesterolemia

May 20, 2003

Applied Research Systems presents a novel series of prostanoid EP2/EP4 modulators

May 20, 2003

Novel isoflavones with utility in hormone balance disorders, cancer, inflammation, etc.

May 20, 2003

Neurogen describes new NPY Y5 receptor modulators in recent patent literature

May 20, 2003

MCH antagonists in early development for obesity and related disorders at Schering-Plough

May 20, 2003

Aldurazyme launched for MPS I

May 19, 2003

New orexin-1 antagonists and their use described in GSK patent

May 19, 2003

Indian team discovers new PPAR agonists with utility in diabetes, dyslipidemia, etc.

May 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...